A stratified precision medicine trial targeting α2A-adrenergic receptor agonism as a treatment for the cognitive biotype of depression
Laura M. Hack, Jenna Jubeir, Rachel Hilton, Leonardo Tozzi, Leyla Boyar, Xue Zhang, Timothy Lyons, Booil Jo, Ruth O’Hara, Alan F. Schatzberg, Leanne M. Williams
Springer Nature ·
2025-10-13
· DOI 10.1038/s44220-025-00510-7
The publisher did not provide an abstract — full text is available via the link below.
Laura M. Hack, Jenna Jubeir, Rachel Hilton, Leonardo Tozzi, Leyla Boyar, Xue Zhang et al. A stratified precision medicine trial targeting α2A-adrenergic receptor agonism as a treatment for the cognitive biotype of depression. // Nature Mental Health. – 2025. – DOI: 10.1038/s44220-025-00510-7. – URL: https://doi.org/10.1038/s44220-025-00510-7
Laura M. Hack, Jenna Jubeir, Rachel Hilton, Leonardo Tozzi, Leyla Boyar, Xue Zhang, Timothy Lyons, Booil Jo, Ruth O’Hara, Alan F. Schatzberg, & Leanne M. Williams (2025). A stratified precision medicine trial targeting α2A-adrenergic receptor agonism as a treatment for the cognitive biotype of depression. Nature Mental Health. https://doi.org/10.1038/s44220-025-00510-7
Laura M. Hack, et al. “A stratified precision medicine trial targeting α2A-adrenergic receptor agonism as a treatment for the cognitive biotype of depression.” Nature Mental Health, 2025. doi:10.1038/s44220-025-00510-7.
@article{Hack2025,
title = {A stratified precision medicine trial targeting α2A-adrenergic receptor agonism as a treatment for the cognitive biotype of depression},
author = {Hack, Laura M. and Jubeir, Jenna and Hilton, Rachel and Tozzi, Leonardo and Boyar, Leyla and Zhang, Xue and Lyons, Timothy and Jo, Booil and O’Hara, Ruth and Schatzberg, Alan F. and Williams, Leanne M.},
journal = {Nature Mental Health},
year = {2025},
doi = {10.1038/s44220-025-00510-7},
url = {https://doi.org/10.1038/s44220-025-00510-7}
}